Logo

Progenity: Surbhi Sarna

Jun 30, 2021

Progenity has appointed Surbhi Sarna to its board of directors effective July 1. She is currently a visiting partner at Y Combinator. Sarna founded nVision Medical and acted as CEO of the medical device company until it was acquired by Boston Scientific in 2018, where she led commercial efforts for nVision until 2020. She previously served in healthcare engineering roles at BioCardia and Abbott Vascular.

Sarna is a board member at medical device company Penumbra and on its audit and nominating and corporate governance committees. She's also on the board of trustees at Astia, which provides access to capital and networks to women entrepreneurs. 

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.